The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11152 malaria professionals are enjoying the free benefits of MalariaWorld today

severe anemia

Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial

September 15, 2021 - 11:28 -- Open Access
Author(s): 
Nkosi-Gondwe T, Robberstad B, Mukaka M, Idro R, Opoka RO, Banda S, Kühl MJ, O Ter Kuile F, Blomberg B, Phiri KS
Reference: 
PLoS One. 2021 Sep 10;16(9):e0255769

The provision of post-discharge malaria chemoprevention (PMC) in children recently admitted with severe anemia reduces the risk of death and re-admissions in malaria endemic countries. The main objective of this trial was to identify the most effective method of delivering dihydroartemesinin-piperaquine to children recovering from severe anemia.

Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria

September 8, 2021 - 15:56 -- Open Access
Author(s): 
Henrici RC, Sautter CL, Bond C, Opoka RO, Namazzi R, Datta D, Ware RE, Conroy AL, John CC
Reference: 
Blood Adv. 2021 Sep 1:bloodadvances.2021004704

Plasmodium falciparum malaria causes morbidity and mortality in African children with sickle cell anemia (SCA), but comparisons of host responses to P. falciparum between children with SCA (HbSS) and HbAA are limited. We assessed parasite biomass and plasma markers of inflammation and endothelial activation in children with HbAA (n=208) or HbSS (n=22) who presented with severe anemia and P. falciparum parasitemia to Mulago Hospital in Kampala, Uganda. Genotyping was performed at study completion.

Malaria Chemoprevention in the Postdischarge Management of Severe Anemia

December 3, 2020 - 13:35 -- Open Access
Author(s): 
Kwambai TK, Dhabangi A, Ter Kuile FO, et al.
Reference: 
N Engl J Med. 2020 Dec 3;383(23):2242-2254

Children who have been hospitalized with severe anemia in areas of Africa in which malaria is endemic have a high risk of readmission and death within 6 months after discharge. No prevention strategy specifically addresses this period.

Subscribe to RSS - severe anemia